Corcept Therapeutics Incorporated
CORT
$69.57
$0.751.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.96% | -25.99% | -1.94% | 50.47% | 28.92% |
| Total Depreciation and Amortization | 136.87% | 158.10% | 69.12% | 72.66% | -78.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 97.02% | 99.26% | 73.39% | -255.69% | -3,021.05% |
| Change in Net Operating Assets | 15.01% | -201.00% | 154.31% | 40.61% | -47.52% |
| Cash from Operations | 6.68% | -78.41% | 907.30% | 39.54% | -2.60% |
| Capital Expenditure | 86.30% | -- | -- | -4,318.92% | -307.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 217.41% | 65.98% | -475.71% | 61.29% | -149.13% |
| Cash from Investing | 216.50% | 64.82% | -476.42% | 59.81% | -149.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 286.47% | 104.56% | 37.48% | 98.51% | 116.09% |
| Repurchase of Common Stock | -2,043.01% | -1,838.08% | -602.01% | -361.77% | 96.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4,687.63% | -7,230.20% | -695.82% | -438.61% | 98.52% |
| Foreign Exchange rate Adjustments | 30,000.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.08% | -366.54% | -140.52% | 114.36% | 83.41% |